Formulation and aerosol canisters, inhalers, and the like containing the formulation

Patent metadata

Field	Value
Publication number	US-11207477-B2
Application number	US-201816613578-A
Country	US
Kind code	B2
Filing date	May 15, 2018
Priority date	May 17, 2017
Publication date	Dec 28, 2021
Grant date	Dec 28, 2021

Abstract

Formulations containing pharmaceutical active agent, propellant, and water at least partially adsorbed on or absorbed within one or more nylon pellets or nylon components of, for example, an inhaler such as a metered dose inhaler. Canisters, typically sealed canisters, containing such formulations. Inhalers, such as metered dose inhalers, containing such canisters. Methods of making and using the same.

First claim

What is claimed is:

1. A method of making an aerosol composition,
the method comprising:
forming a composition, the composition comprising a liquid comprising a propellant, the propellant comprising one or more of HFA- 134 a and HFA- 227 , and one or more pharmaceutical active agents dissolved or dispersed in the liquid, wherein the one or more pharmaceutical active agents is a hydrate,
soaking one or more nylon pellets in water to form one or more water soaked nylon pellets, wherein at least some of the water is adsorbed on or absorbed within the one or more water soaked nylon pellets,
removing at least some water from a surface of the one or more water soaked nylon pellets, and
adding the one or more water soaked nylon pellets obtained from the removing step to the composition to form the aerosol composition.

2. The method of claim 1 , wherein at least one of the one or more pharmaceutical active agents is a hydrate of ipratropium or a hydrate of an ipratropium salt.

3. The method of claim 1 , wherein at least one of the one or more pharmaceutical active agents is ipratropium bromide monohydrate.

4. The method of claim 1 , wherein the composition further comprises albuterol.

5. The method of claim 1 , wherein the nylon is nylon 6,6.

6. The method of claim 1 , wherein the propellant comprises HFA- 134 a.

7. The method of claim 1 , wherein at least some of the water is dissolved or dispersed in the liquid and the concentration of the water dissolved or dispersed in the liquid is between 50 ppm and 500 ppm based on the liquid and any components dissolved or dispersed in the liquid.

8. The method of claim 1 , wherein the step of removing at least some water is accomplished by blotting the water soaked nylon pellets.

Assignees

• Kindeva Drug Delivery Lp

Inventors

• Hodson Peter D

Classifications

• B65D83/141

  specially adapted for specific contents or propellants · CPC title

• A61K31/46 Primary

  8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine · CPC title

• A61K47/34

  Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title

• A61K47/06

  Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite · CPC title

• A61M2209/06

  Packaging for specific medical equipment · CPC title